Cargando…
The Use of Peripheral μ-Opioid Receptor Antagonists (PAMORA) in the Management of Opioid-Induced Constipation: An Update on Their Efficacy and Safety
Peripherally acting μ-opioid receptor antagonists (PAMORAs) constitute a class of drugs which reverse opioid-induced constipation (OIC) with similar opioid analgesic effects. OIC differs from other forms of constipation in that it is an iatrogenic condition that occurs when an opioid acts on the den...
Autores principales: | Pergolizzi Jr, Joseph V, Christo, Paul J, LeQuang, Jo Ann, Magnusson, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7075239/ https://www.ncbi.nlm.nih.gov/pubmed/32210534 http://dx.doi.org/10.2147/DDDT.S221278 |
Ejemplares similares
-
Efficacy and Safety of Peripherally Acting μ-Opioid Receptor Antagonist (PAMORAs) for the Management of Patients With Opioid-Induced Constipation: A Systematic Review
por: Rekatsina, Martina, et al.
Publicado: (2021) -
Peripherally acting μ-opioid receptor antagonists as treatment options for constipation in noncancer pain patients on chronic opioid therapy
por: Pergolizzi, Joseph V, et al.
Publicado: (2017) -
Stopping or Decreasing Opioid Therapy in Patients on Chronic Opioid Therapy
por: Pergolizzi, Joseph V., et al.
Publicado: (2019) -
Opioid Therapy in Cancer Patients and Survivors at Risk of Addiction, Misuse or Complex Dependency
por: Pergolizzi, Joseph V., et al.
Publicado: (2021) -
Suicide by Opioid: Exploring the Intentionality of the Act
por: Pergolizzi, Joseph, et al.
Publicado: (2021)